Genmab A/S (GNMSF) Change in Acquisitions & Divestments (2023 - 2026)

Genmab A (GNMSF) has 4 years of Change in Acquisitions & Divestments data on file, last reported at -$4.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 300.0% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.0 million (up 42.11% YoY) and the FY2024 annual result came in at -$8.0 million, down 100.0% from the prior year.
• Change in Acquisitions & Divestments declined to -$4.0 million in Q1 2026, from -$3.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of -$1.0 million in Q1 2025 to a low of -$8.0 million in Q4 2024.
• A 4-year average of -$4.0 million and a median of -$4.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments surged 66.67% — and 2026, when it sank 300.0%.
• Tracing GNMSF's Change in Acquisitions & Divestments over 4 years: stood at -$4.0 million in 2023, then sank by 100.0% to -$8.0 million in 2024, then jumped by 62.5% to -$3.0 million in 2025, then plunged by 33.33% to -$4.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at -$4.0 million (Q1 2026), -$3.0 million (Q3 2025), and -$3.0 million (Q2 2025), per Business Quant data.